Experts urge caution over drug company campaigns to destigmatise obesity
Destigmatising obesity is the right thing to do, but commercial interests require careful scrutiny We should be wary of campaigns by pharmaceutical companies to destigmatise obesity, say experts in The BMJ today. Michael Viggars and colleagues argue that, while destigmatising obesity is the right thing to do, there is a ...

